274 related articles for article (PubMed ID: 33721148)
21. Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: a French sentinel node multicenter cohort study.
Houvenaeghel G; Classe JM; Garbay JR; Giard S; Cohen M; Faure C; Hélène C; Belichard C; Uzan S; Hudry D; Azuar P; Villet R; Penault Llorca F; Tunon de Lara C; Goncalves A; Esterni B;
Breast; 2014 Oct; 23(5):561-6. PubMed ID: 24874284
[TBL] [Abstract][Full Text] [Related]
22. [Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
[TBL] [Abstract][Full Text] [Related]
23. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
24. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
26. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
27. Clinical effect of the pathological axillary assessment method in breast cancer without clinical nodal metastasis.
Sasada S; Masumoto N; Emi A; Kadoya T; Arihiro K; Okada M
Breast Cancer; 2021 Sep; 28(5):1016-1022. PubMed ID: 33740208
[TBL] [Abstract][Full Text] [Related]
28. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
[TBL] [Abstract][Full Text] [Related]
29. Can axillary node dissection be safely omitted in the elderly? A retrospective study on axillary management of early breast cancer in older women.
Esposito E; Sollazzo V; Di Micco R; Cervotti M; Luglio G; Benassai G; Mozzillo P; Perrotta S; Desiato V; Amato B; Forestieri P; Limite G
Int J Surg; 2016 Sep; 33 Suppl 1():S114-8. PubMed ID: 27353842
[TBL] [Abstract][Full Text] [Related]
30. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
[TBL] [Abstract][Full Text] [Related]
31. Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection?
Moo TA; Edelweiss M; Hajiyeva S; Stempel M; Raiss M; Zabor EC; Barrio A; Morrow M
Ann Surg Oncol; 2018 Jun; 25(6):1488-1494. PubMed ID: 29572705
[TBL] [Abstract][Full Text] [Related]
32. Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells.
Pepels MJ; de Boer M; Bult P; van Dijck JA; van Deurzen CH; Menke-Pluymers MB; van Diest PJ; Borm GF; Tjan-Heijnen VC
Ann Surg; 2012 Jan; 255(1):116-21. PubMed ID: 22183034
[TBL] [Abstract][Full Text] [Related]
33. Risk stratification of patients with early breast cancer.
Roy PG; Chan SM; Ng V; Smith BM; Umeh H; Courtney SP
Clin Breast Cancer; 2014 Feb; 14(1):68-73. PubMed ID: 24252507
[TBL] [Abstract][Full Text] [Related]
34. Lymph node micrometastases and outcome of endometrial cancer.
Ignatov A; Lebius C; Ignatov T; Ivros S; Knueppel R; Papathemelis T; Ortmann O; Eggemann H
Gynecol Oncol; 2019 Sep; 154(3):475-479. PubMed ID: 31345606
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of a population-based series of early breast cancer patients with micrometastases and isolated tumour cells in axillary lymph nodes.
van der Heiden-van der Loo M; Schaapveld M; Ho VK; Siesling S; Rutgers EJ; Peeters PH
Ann Oncol; 2013 Nov; 24(11):2794-801. PubMed ID: 23864096
[TBL] [Abstract][Full Text] [Related]
36. Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).
Agresti R; Martelli G; Sandri M; Tagliabue E; Carcangiu ML; Maugeri I; Pellitteri C; Ferraris C; Capri G; Moliterni A; Bianchi G; Mariani G; Trecate G; Lozza L; Langer M; Rampa M; Gennaro M; Greco M; Menard S; Pierotti MA
Cancer; 2014 Mar; 120(6):885-93. PubMed ID: 24323615
[TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ.
Magnoni F; Massari G; Santomauro G; Bagnardi V; Pagan E; Peruzzotti G; Galimberti V; Veronesi P; Sacchini VS
Br J Surg; 2019 Mar; 106(4):375-383. PubMed ID: 30791092
[TBL] [Abstract][Full Text] [Related]
38. Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study.
Maaskant-Braat AJ; van de Poll-Franse LV; Voogd AC; Coebergh JW; Roumen RM; Nolthenius-Puylaert MC; Nieuwenhuijzen GA
Breast Cancer Res Treat; 2011 May; 127(1):195-203. PubMed ID: 20680679
[TBL] [Abstract][Full Text] [Related]
39. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Galimberti V; Cole BF; Viale G; Veronesi P; Vicini E; Intra M; Mazzarol G; Massarut S; Zgajnar J; Taffurelli M; Littlejohn D; Knauer M; Tondini C; Di Leo A; Colleoni M; Regan MM; Coates AS; Gelber RD; Goldhirsch A;
Lancet Oncol; 2018 Oct; 19(10):1385-1393. PubMed ID: 30196031
[TBL] [Abstract][Full Text] [Related]
40.
Wang J; Fan T; He Y; Chen X; Fan Z; Xie Y; Wang T; Li J; Ouyang T
Breast Cancer Res Treat; 2018 Apr; 168(2):365-370. PubMed ID: 29209873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]